PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30905126-11	2019	Likewise, Iba-1 and GFAP immunoreactivities were enhanced by the CUMS protocol and this action was reversed by BBG treatment.	coomassie Brilliant Blue	111-114	glial fibrillary acidic protein	Rattus norvegicus	20-24	
31059094-3	2019	The results demonstrated that the levels of P2X7R, GLU and GFAP were significantly upregulated in rats with spontaneous recurrent seizures, whereas they were reduced in rats that were treated with brilliant blue G (BBG), a P2X7R antagonist.	coomassie Brilliant Blue	197-213	glial fibrillary acidic protein	Rattus norvegicus	59-63	
31059094-3	2019	The results demonstrated that the levels of P2X7R, GLU and GFAP were significantly upregulated in rats with spontaneous recurrent seizures, whereas they were reduced in rats that were treated with brilliant blue G (BBG), a P2X7R antagonist.	coomassie Brilliant Blue	215-218	glial fibrillary acidic protein	Rattus norvegicus	59-63	
26921791-8	2016	Administration of Brilliant blue G, an antagonist of P2X7R, significantly decreases astrogliosis as confirmed by immunohistochemical analysis and observation of decreased levels of GFAP and S100beta.	coomassie Brilliant Blue	18-34	glial fibrillary acidic protein	Rattus norvegicus	181-185